Patents by Inventor Larry Blatt

Larry Blatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for predicting liver fibrosis treatment efficacy
    Publication number: 20060198787
    Abstract: The invention relates to methods for predicting or determining the efficacy of certain medical treatments, especially treatments for liver fibrosis. The methods of the invention include measuring interferon-induced ligands prior to initiating treatment and at some time following the initiation of treatment to predict the clinical outcome of the treatment.
    Type: Application
    Filed: February 17, 2006
    Publication date: September 7, 2006
    Inventor: Larry Blatt
  • Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon
    Patent number: 5980884
    Abstract: Methods for the retreatment, using a therapeutically effective amount of interferon consensus, of patients with HCV who exhibit serum ALT values above the upper limit of normal after previous treatment with interferon.
    Type: Grant
    Filed: February 5, 1996
    Date of Patent: November 9, 1999
    Assignee: Amgen, Inc.
    Inventors: Larry Blatt, Michael Klein